Adverse Drug Reactions: Most of the undesirable effects reported by the subjects occur during the early phase of treatment and are mainly dose dependent.
Allergic reactions (including symptoms of anaphylaxis) occur rarely during use of nicotine products.
Irritation in the mouth and throat may be experienced, however most subjects adapt to this with ongoing use.
The chewing gum may stick to, and may in rare cases damage dentures.
Clinical Trial Data: The safety of nicotine from clinical trial data is based on data on a meta-analysis of randomized clinical trials (RCTs) for the treatment of smoking cessation. (See Table 3.)
Post Marketing Data: Adverse drug reactions (ADRs) first identified during post-marketing experience with nicotine are presented. Frequencies are provided according to the following convention: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000, <1/1,000; Very rare <1/10,000; Not known (cannot be estimated from the available data). (See Tables 4 and 5.)
View ADR Reporting Link
Sign Out